Geoffrey Mackay - Dec 8, 2022 Form 4 Insider Report for AVROBIO, Inc. (AVRO)

Role
President & CEO, Director
Signature
/s/ Steven Avruch, Attorney-in-Fact for Geoffrey MacKay
Stock symbol
AVRO
Transactions as of
Dec 8, 2022
Transactions value $
$0
Form type
4
Date filed
12/9/2022, 04:30 PM
Previous filing
Jun 13, 2022
Next filing
Dec 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Stock Option (Right to Buy) Award $0 +388K $0.00 388K Dec 8, 2022 Common Stock 388K $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares shall vest and become exercisable on the first anniversary of the grant date, and the remaining 50% shall vest in equal monthly installments thereafter over a one-year period.